FdaApplication
NDA 021689
Identifiers
- fda_app_no: NDA021689
Properties
| Property | Value |
|---|---|
| applicant_name | ASTRAZENECA PHARMACEUTICALS LP |
| application_type | NDA |
| approval_date | 2005-03-31 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NEXIUM IV | ESOMEPRAZOLE SODIUM | EQ 20MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INTRAVENOUS |
| NEXIUM IV | ESOMEPRAZOLE SODIUM | EQ 40MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INTRAVENOUS |
2 products